Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling

Fibroblast growth factor receptor 2 (FGFR2) was demonstrated to correlate to the progression and prognosis of intrahepatic cholangiocarcinoma (ICC) by numerous evidences. However, as a well‐recognized suppressor of FGFR2 signalling, the clinical significance of Sprouty (SPRY) family of ICC has not b...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yun‐Fei, Liu, Hong‐Da, Liu, Zeng‐Li, Pan, Chang, Yang, Xiao‐Qing, Ning, Shang‐Lei, Zhang, Zong‐Li, Guo, Sen, Yu, Jin‐Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201365/
https://www.ncbi.nlm.nih.gov/pubmed/30160357
http://dx.doi.org/10.1111/jcmm.13833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201365/
https://www.ncbi.nlm.nih.gov/pubmed/30160357
http://dx.doi.org/10.1111/jcmm.13833

Ejemplares similares